| 标题 |
Comparison of outcomes of second-line durvalumab plus tremelimumab versus lenvatinib following first-line atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:PloS one 作者:Nishioka C; Tahata Y; Maesaka K; Kai M; Shirai K; et al 出版日期:2026/05/07 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)